NIH-funded research NIH-funded research

Understanding how cells maintain protein quality control

Official title: Regulation and Mechanisms of ER Proteostasis

Funded at University of Iowa · NIH-10937803 · Data updated 2026-11-12

This study is looking at how cells take care of proteins that don't fold correctly, which is important for people with certain diseases, to see how different cells decide whether to break down these faulty proteins in different ways.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$381,251
NIH project number1R35GM154959-01
Project IDNIH-10937803 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions related to protein misfolding or degradation, such as cystic fibrosis or Gaucher disease.

Less likely to help

Patients with conditions unrelated to protein quality control mechanisms may not benefit from this research.

What this research studies

This research investigates the mechanisms by which cells manage protein quality control, focusing on the endoplasmic reticulum (ER). It aims to understand how misfolded proteins are identified and directed for degradation through two main pathways: ER-associated degradation (ERAD) and ER-autophagy (ER-phagy). The study will explore the factors that influence which pathway is used for different proteins and how these processes vary across different cell types. By using specific disease-related protein mutations as models, the research seeks to uncover the principles governing these critical cellular functions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases caused by protein misfolding, such as cystic fibrosis and Gaucher disease.

How similar studies have gone: Previous research has shown success in understanding protein degradation pathways, but this study aims to explore novel aspects of these mechanisms.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Schultz, Mark Louis — University of Iowa
  • Study coordinator: Schultz, Mark Louis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.